RP23-221K3.2 inhibitors represent a class of small molecules or compounds designed to modulate the activity of the RP23-221K3.2 protein, which is typically involved in various intracellular signaling pathways. This protein is often categorized within the kinases, enzymes that play a crucial role in transferring phosphate groups from high-energy molecules like ATP to specific substrates. The process of phosphorylation is a critical biochemical mechanism that regulates numerous cellular functions, including gene expression, cell division, metabolism, and other essential signaling cascades. Inhibitors targeting RP23-221K3.2 act by disrupting its kinase activity, preventing the phosphorylation of its downstream targets, thereby altering the normal regulatory mechanisms within the cell. This inhibition can provide insights into the protein's natural role and help researchers understand the broader impacts of kinase regulation on complex intracellular processes.
The chemical structures of RP23-221K3.2 inhibitors are diverse, often containing functional groups that interact specifically with the ATP-binding domain or other regulatory regions of the kinase. Structural modifications of these inhibitors can fine-tune their specificity and potency, ensuring that they preferentially bind to RP23-221K3.2 without significantly affecting other kinases. The development of these inhibitors relies heavily on structure-activity relationship (SAR) studies, which correlate specific chemical changes in the inhibitor with biological activity. By focusing on the biophysical and biochemical properties of RP23-221K3.2 inhibitors, researchers can probe the dynamics of kinase-substrate interactions, offering valuable insights into the fundamental biological processes governed by these enzymes. The ability to precisely inhibit this protein also aids in mapping the extensive signaling networks it influences, contributing to our understanding of cellular behavior in various contexts.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D inhibits RNA synthesis by intercalating DNA, preventing OFD1 mRNA transcription. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Cycloheximide inhibits protein synthesis, potentially preventing the translation of OFD1 mRNA into the protein. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
5-Fluorouracil interferes with nucleotide synthesis, potentially disrupting the production of OFD1 mRNA. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $163.00 $316.00 | 436 | |
Puromycin incorporates into peptide chains, potentially leading to premature termination of OFD1 protein synthesis. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin inhibits protein synthesis, potentially impacting the translation of OFD1 mRNA into the protein. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $95.00 $322.00 $663.00 $1438.00 | 6 | |
Rifampicin inhibits bacterial RNA synthesis, which may indirectly impact OFD1 mRNA transcription in bacterial expression systems. | ||||||
Benzo[a]pyrene | 50-32-8 | sc-257130 | 1 g | $439.00 | 4 | |
Thiolutin inhibits RNA synthesis, potentially preventing the transcription of OFD1 mRNA. | ||||||
Blasticidin S Hydrochloride | 3513-03-9 | sc-204655A sc-204655 | 25 mg 100 mg | $360.00 $475.00 | 20 | |
Blasticidin S inhibits protein synthesis, potentially preventing the translation of OFD1 mRNA into the protein. | ||||||
Siomycin A | 12656-09-6 | sc-202339 sc-202339-CW sc-202339A sc-202339B | 500 µg 500 µg 2.5 mg 25 mg | $439.00 $449.00 $1326.00 $10200.00 | 4 | |
Siomycin A inhibits RNA synthesis, potentially preventing the transcription of OFD1 mRNA. | ||||||